AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Lokelma (sodium zirconium cyclosilicate) by Quarter
Lokelma (sodium zirconium cyclosilicate) — Emerging Markets YoY CER (%) (%)
AstraZeneca Lokelma (sodium zirconium cyclosilicate): 40.0% in Q2 2026, down 14.0 pts from a year earlier.
Where the Q2 2026 figure comes from
“|| Lokelma | 221 | | 26 | | 26 | | 85 | | 13 | | 48 | | 47 | | 40 | | 47 | | 54 | | 46 | | 41 | | 12 | | 22”
Source: Form 6-K FY2026Q2 Earnings Release ↗
Reported in Form 6-K / 20-F Product Sales Table.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Lokelma (sodium zirconium cyclosilicate) — Emerging Markets YoY CER (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 40.0% | -14.0 pts | Form 6-K FY2026Q2 Earnings Release ↗ |
| Q1 2026 | Mar 31, 2026 | 41.0% | -13.0 pts | Form 6-K FY2026Q1 Earnings Release ↗ |
| Q4 2025 | Dec 31, 2025 | 61.0% | +11.0 pts | Form 6-K FY2025Q4 Earnings Release ↗ |
| Q3 2025 | Sep 30, 2025 | 41.0% | – | Form 6-K FY2025Q3 Earnings Release ↗ |
| Q2 2025 | Jun 30, 2025 | 54.0% | -24.0 pts | Form 6-K FY2025Q2 Earnings Release ↗ |
| Q1 2025 | Mar 31, 2025 | 54.0% | -36.0 pts | Form 6-K FY2025Q1 Earnings Release ↗ |
| Q4 2024 | Dec 31, 2024 | 50.0% | – | Form 6-K FY2024Q4 Earnings Release ↗ |
| Q2 2024 | Jun 30, 2024 | 78.0% | – | Form 6-K FY2024Q2 Earnings Release ↗ |
| Q1 2024 | Mar 31, 2024 | 90.0% | – | Form 6-K FY2024Q1 Earnings Release ↗ |
| Q3 2023 | Sep 30, 2023 | 48.0% | – | Form 6-K FY2023Q3 Earnings Release ↗ |
| Q3 2021 | Sep 30, 2021 | -65.0% | – | Form 6-K FY2021Q3 Earnings Release ↗ |
| Q2 2021 | Jun 30, 2021 | 78.0% | – | Form 6-K FY2021Q2 Earnings Release ↗ |
Cite this data
StockData. (2026). AstraZeneca Lokelma (sodium zirconium cyclosilicate) (%), quarterly Q2 2021–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-lokelma-em-cer-yoy
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.
See a number that looks wrong?